BURLINGTON PRIMARY CARE — All Prescriptions & Medications — Page 8
Practice Code: D83008 | IPSWICH, IP1 2EU
Showing results 351-400 of 659
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Reboxetine | 66 | 1,516 | £461 | +328.5% ▲ |
| Alprostadil | 66 | 274 | £3.0K | +285.9% ▲ |
| Tacrolimus | 66 | 2,220 | £1.7K | +22.4% ▲ |
| Metronidazole | 66 | 2,785 | £706 | +75.6% ▲ |
| Orlistat | 65 | 5,460 | £1.3K | -21.1% ▼ |
| Trihexyphenidyl hydrochloride | 65 | 1,232 | £61 | +129.2% ▲ |
| Alfuzosin hydrochloride | 65 | 2,322 | £495 | -9.1% ▼ |
| Imipramine hydrochloride | 64 | 5,725 | £450 | +151.0% ▲ |
| Metronidazole | 64 | 2,560 | £263 | +867.8% ▲ |
| Loratadine | 63 | 1,826 | £47 | -69.8% ▼ |
| 63 | 10.3K | £285 | +388.3% ▲ | |
| Water for injection | 62 | 1,860 | £601 | +83.3% ▲ |
| 62 | 3,174 | £6.1K | +55.4% ▲ | |
| Powder 1.6 kcal/ml milkshake (0913011) | 61 | 10.8K | £1.5K | -18.2% ▼ |
| 61 | 6,055 | £8.8K | +246.0% ▲ | |
| Pramipexole | 60 | 2,138 | £4.7K | -38.9% ▼ |
| Ferrous gluconate | 60 | 2,914 | £83 | +25.5% ▲ |
| Celecoxib | 60 | 3,330 | £232 | -9.1% ▼ |
| Other individually formulated bought in preparations | 60 | 3,776 | £3.8K | +83.6% ▲ |
| 60 | 450 | £1.3K | +67.9% ▲ | |
| Adrenaline | 59 | 96 | £5.8K | -6.4% ▼ |
| Insulin Lispro | 59 | 351 | £2.0K | -22.9% ▼ |
| Hydrocort sodiumphos | 59 | 2,458 | £856 | +670.7% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 59 | 1,860 | £811 | -12.0% ▼ |
| Pericyazine | 58 | 1,218 | £1.2K | -47.5% ▼ |
| 58 | 1,660 | £7.5K | +28.3% ▲ | |
| Primidone | 57 | 3,764 | £4.8K | +60.2% ▲ |
| Nicotine | 57 | 1,118 | £1.5K | +0.9% vs avg |
| Brivaracetam | 56 | 2,996 | £6.9K | +64.6% ▲ |
| Medroxyprogesterone acetate | 56 | 1,322 | £300 | +46.3% ▲ |
| Desmopressin acetate | 56 | 1,890 | £2.3K | +7.4% ▲ |
| Midazolam hydrochloride | 56 | 546 | £307 | +36.8% ▲ |
| Meloxicam | 55 | 2,360 | £62 | -16.8% ▼ |
| Zolmitriptan | 54 | 864 | £2.9K | -16.8% ▼ |
| Betamethasone esters | 54 | 3,720 | £355 | -10.5% ▼ |
| Azelastine hydrochloride | 53 | 1,166 | £529 | +372.9% ▲ |
| Sucralfate | 52 | 13.0K | £15.2K | +519.2% ▲ |
| Levomepromazine hydrochloride | 52 | 506 | £969 | +125.9% ▲ |
| Magnesium glycerophosphate | 52 | 4,898 | £2.1K | +278.5% ▲ |
| Latanoprost and timolol | 52 | 1,565 | £711 | -31.9% ▼ |
| Brinzolamide and timolol | 52 | 400 | £546 | +37.6% ▲ |
| 52 | 1,560 | £327 | +132.9% ▲ | |
| Glycopyrronium bromide | 50 | 1,500 | £1.3K | +34.2% ▲ |
| Lisdexamfetamine dimesylate | 50 | 1,481 | £3.8K | -58.1% ▼ |
| Neomycin sulfate | 50 | 840 | £106 | -15.7% ▼ |
| Diphtheria | 50 | 50 | £362 | -25.1% ▼ |
| Dabigatran etexilate | 49 | 2,060 | £1.7K | -5.3% ▼ |
| 49 | 1,570 | £605 | +180.8% ▲ | |
| 49 | 10.2K | £377 | -51.8% ▼ | |
| Quinine bisulfate | 48 | 1,286 | £240 | +23.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.